|
KMID : 0931320140140020091
|
|
대한상부위장관.헬리코박터학회지
2014 Volume.14 No. 2 p.91 ~ p.94
|
|
|
Physicians’ Opinion on Asymptomatic Reflux Esophagitis and Short Segment Barrett’s Esophagus
|
|
Kim Jung-Hee
Lee Jun-Haeng
Lee Dong-Ho
|
|
|
Abstract
|
|
|
Background/Aims: There are controversies on the management of asymptomatic reflux esophagitis and short-segment Barrett’sesophagus in Korea.
Materials and Methods: From October 2012 to February 2013, an iPAD app-based survey for 10 questions about asymptomatic re-flux esophagitis and short segment Barrett’s esophagus was performed. A total of 585 physicians, most of them primary care physi-cians, answered the survey.
Results: For asymptomatic individuals with LA group A reflux esophagitis, physicians recommend non-pharmacologic treatment in 46.2%, proton pump inhibitor (PPI) in 33.8%, and histamine-2 receptor antagonists (H2RA) in 17.3%. For asymptomatic in-dividuals with LA group B reflux esophagitis, physicians recommend PPI in 51.5%, non-pharmacologic treatment in 27.0%, and H2RA in 20.6%. The proportion of non-pharmacologic treatment in LA group A and B was statistically significant (P<0.01). For endoscopically suspected columnar metaplasia less than 1 cm, 50.4% of respondents answered that they would take biopsies. For patients with histologically confirmed Barrett’s esophagus, 83.7 percent of respondents answered that they would prescribe PPI or H2RA, but the duration of anti-acid treatment was mostly for a couple of months only.
Conclusions: There is great discrepancy on the management of asymptomatic reflux esophagitis and short segment Barrett’s esoph-agus in Korea.
|
|
|
KEYWORD
|
|
|
Gastrointestinal reflux disease, Barrett’s esophagus
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|